Literature DB >> 25064846

The multifaceted regulation and functions of PKM2 in tumor progression.

Zongwei Li1, Peng Yang1, Zhuoyu Li2.   

Abstract

Tumor cells undergo metabolic rewiring from oxidative phosphorylation towards aerobic glycolysis to maintain the increased anabolic requirements for cell proliferation. It is widely accepted that specific expression of the M2 type pyruvate kinase (PKM2) in tumor cells contributes to this aerobic glycolysis phenotype. To date, researchers have uncovered myriad forms of functional regulation for PKM2, which confers a growth advantage on the tumor cells to enable them to adapt to various microenvironmental signals. Here the richness of our understanding on the modulations and functions of PKM2 in tumor progression is reviewed, and some new insights into the paradoxical expression and functional differences of PKM2 in distinct cancer types are offered.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aerobic glycolysis; Dimer; Pyruvate kinase M2; Tetramer; Tumor progression

Mesh:

Substances:

Year:  2014        PMID: 25064846     DOI: 10.1016/j.bbcan.2014.07.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  40 in total

Review 1.  Pyruvate and Metabolic Flexibility: Illuminating a Path Toward Selective Cancer Therapies.

Authors:  Kristofor A Olson; John C Schell; Jared Rutter
Journal:  Trends Biochem Sci       Date:  2016-02-10       Impact factor: 13.807

Review 2.  Dysregulated glycolysis as an oncogenic event.

Authors:  Takumi Mikawa; Matilde E LLeonart; Akifumi Takaori-Kondo; Nobuya Inagaki; Masayuki Yokode; Hiroshi Kondoh
Journal:  Cell Mol Life Sci       Date:  2015-01-22       Impact factor: 9.261

3.  CHIP/Stub1 regulates the Warburg effect by promoting degradation of PKM2 in ovarian carcinoma.

Authors:  Y Shang; J He; Y Wang; Q Feng; Y Zhang; J Guo; J Li; S Li; Y Wang; G Yan; F Ren; Y Shi; J Xu; N Zeps; Y Zhai; D He; Z Chang
Journal:  Oncogene       Date:  2017-03-27       Impact factor: 9.867

Review 4.  Oxidative Stress in Cancer.

Authors:  John D Hayes; Albena T Dinkova-Kostova; Kenneth D Tew
Journal:  Cancer Cell       Date:  2020-07-09       Impact factor: 31.743

5.  KSHV induces aerobic glycolysis and angiogenesis through HIF-1-dependent upregulation of pyruvate kinase 2 in Kaposi's sarcoma.

Authors:  Tao Ma; Harsh Patel; Savalan Babapoor-Farrokhran; Renty Franklin; Gregg L Semenza; Akrit Sodhi; Silvia Montaner
Journal:  Angiogenesis       Date:  2015-06-20       Impact factor: 9.596

6.  Hsp90 and PKM2 Drive the Expression of Aromatase in Li-Fraumeni Syndrome Breast Adipose Stromal Cells.

Authors:  Kotha Subbaramaiah; Kristy A Brown; Heba Zahid; Gabriel Balmus; Robert S Weiss; Brittney-Shea Herbert; Andrew J Dannenberg
Journal:  J Biol Chem       Date:  2016-06-01       Impact factor: 5.157

7.  Pyruvate kinase M2 promotes pancreatic ductal adenocarcinoma invasion and metastasis through phosphorylation and stabilization of PAK2 protein.

Authors:  Tsu-Yao Cheng; Yi-Chieh Yang; Hsiu-Po Wang; Yu-Wen Tien; Chia-Tung Shun; Hsin-Yi Huang; Michael Hsiao; Kuo-Tai Hua
Journal:  Oncogene       Date:  2018-01-16       Impact factor: 9.867

8.  Pyruvate Kinase Isozyme M2 Plays a Critical Role in the Interactions Between Pancreatic Stellate Cells and Cancer Cells.

Authors:  Atsushi Masamune; Shin Hamada; Naoki Yoshida; Tatsuhide Nabeshima; Tooru Shimosegawa
Journal:  Dig Dis Sci       Date:  2018-04-04       Impact factor: 3.199

9.  c-Myc and AMPK Control Cellular Energy Levels by Cooperatively Regulating Mitochondrial Structure and Function.

Authors:  Lia R Edmunds; Lokendra Sharma; Huabo Wang; Audry Kang; Sonia d'Souza; Jie Lu; Michael McLaughlin; James M Dolezal; Xiaoli Gao; Susan T Weintraub; Ying Ding; Xuemei Zeng; Nathan Yates; Edward V Prochownik
Journal:  PLoS One       Date:  2015-07-31       Impact factor: 3.240

10.  Dihydropyrimidinase Like 2 Promotes Bladder Cancer Progression via Pyruvate Kinase M2-Induced Aerobic Glycolysis and Epithelial-Mesenchymal Transition.

Authors:  Jun Zou; Ruiyan Huang; Yanfei Chen; Xiaoping Huang; Huajun Li; Peng Liang; Shan Chen
Journal:  Front Cell Dev Biol       Date:  2021-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.